189 related articles for article (PubMed ID: 32655423)
1. The Effect of Ketamine on Electrophysiological Connectivity in Major Depressive Disorder.
Nugent AC; Ballard ED; Gilbert JR; Tewarie PK; Brookes MJ; Zarate CA
Front Psychiatry; 2020; 11():519. PubMed ID: 32655423
[TBL] [Abstract][Full Text] [Related]
2. Ketamine and Attentional Bias Toward Emotional Faces: Dynamic Causal Modeling of Magnetoencephalographic Connectivity in Treatment-Resistant Depression.
Gilbert JR; Galiano CS; Nugent AC; Zarate CA
Front Psychiatry; 2021; 12():673159. PubMed ID: 34220581
[TBL] [Abstract][Full Text] [Related]
3. Glutamatergic Signaling Drives Ketamine-Mediated Response in Depression: Evidence from Dynamic Causal Modeling.
Gilbert JR; Yarrington JS; Wills KE; Nugent AC; Zarate CA
Int J Neuropsychopharmacol; 2018 Aug; 21(8):740-747. PubMed ID: 29668918
[TBL] [Abstract][Full Text] [Related]
4. Preliminary differences in resting state MEG functional connectivity pre- and post-ketamine in major depressive disorder.
Nugent AC; Robinson SE; Coppola R; Zarate CA
Psychiatry Res Neuroimaging; 2016 Aug; 254():56-66. PubMed ID: 27362845
[TBL] [Abstract][Full Text] [Related]
5. Ketamine Alters Electrophysiological Responses to Emotional Faces in Major Depressive Disorder.
Lundin NB; Sepe-Forrest L; Gilbert JR; Carver FW; Furey ML; Zarate CA; Nugent AC
J Affect Disord; 2021 Jan; 279():239-249. PubMed ID: 33074143
[TBL] [Abstract][Full Text] [Related]
6. Evidence that Subanesthetic Doses of Ketamine Cause Sustained Disruptions of NMDA and AMPA-Mediated Frontoparietal Connectivity in Humans.
Muthukumaraswamy SD; Shaw AD; Jackson LE; Hall J; Moran R; Saxena N
J Neurosci; 2015 Aug; 35(33):11694-706. PubMed ID: 26290246
[TBL] [Abstract][Full Text] [Related]
7. Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects.
Nugent AC; Ballard ED; Gould TD; Park LT; Moaddel R; Brutsche NE; Zarate CA
Mol Psychiatry; 2019 Jul; 24(7):1040-1052. PubMed ID: 29487402
[TBL] [Abstract][Full Text] [Related]
8. Ketamine, but Not the NMDAR Antagonist Lanicemine, Increases Prefrontal Global Connectivity in Depressed Patients.
Abdallah CG; Dutta A; Averill CL; McKie S; Akiki TJ; Averill LA; Deakin JFW
Chronic Stress (Thousand Oaks); 2018; 2():. PubMed ID: 30263977
[TBL] [Abstract][Full Text] [Related]
9. The functional connectivity of the middle frontal cortex predicts ketamine's outcome in major depressive disorder.
Zhang F; Wang C; Lan X; Li W; Fu L; Ye Y; Liu H; Wu K; Zhou Y; Ning Y
Front Neurosci; 2022; 16():956056. PubMed ID: 36188452
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous EEG/fMRI recorded during ketamine infusion in patients with major depressive disorder.
McMillan R; Sumner R; Forsyth A; Campbell D; Malpas G; Maxwell E; Deng C; Hay J; Ponton R; Sundram F; Muthukumaraswamy S
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109838. PubMed ID: 31843628
[TBL] [Abstract][Full Text] [Related]
11. κ-Opioid Receptor Plasma Levels Are Associated With Sex and Diagnosis of Major Depressive Disorder But Not Response to Ketamine.
Quintanilla B; Medeiros GC; Greenstein D; Yuan P; Johnston JN; Park LT; Goes FS; Gould TD; Zarate CA
J Clin Psychopharmacol; 2023 Mar-Apr 01; 43(2):89-96. PubMed ID: 36821406
[TBL] [Abstract][Full Text] [Related]
12. Synaptic potentiation and rapid antidepressant response to ketamine in treatment-resistant major depression: A replication study.
Nugent AC; Wills KE; Gilbert JR; Zarate CA
Psychiatry Res Neuroimaging; 2019 Jan; 283():64-66. PubMed ID: 30551012
[TBL] [Abstract][Full Text] [Related]
13. Neurophysiological evidence that frontoparietal connectivity and GABA-A receptor changes underpin the antidepressant response to ketamine.
Sumner RL; McMillan RL; Forsyth A; Muthukumaraswamy SD; Shaw AD
Transl Psychiatry; 2024 Feb; 14(1):116. PubMed ID: 38402231
[TBL] [Abstract][Full Text] [Related]
14. Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review.
du Jardin KG; Müller HK; Elfving B; Dale E; Wegener G; Sanchez C
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():27-38. PubMed ID: 27262695
[TBL] [Abstract][Full Text] [Related]
15. A randomized placebo-controlled PET study of ketamine´s effect on serotonin
Tiger M; Veldman ER; Ekman CJ; Halldin C; Svenningsson P; Lundberg J
Transl Psychiatry; 2020 Jun; 10(1):159. PubMed ID: 32475989
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers of ketamine's antidepressant effect: a clinical review of genetics, functional connectivity, and neurophysiology.
Alario AA; Niciu MJ
Chronic Stress (Thousand Oaks); 2021; 5():24705470211014210. PubMed ID: 34159281
[TBL] [Abstract][Full Text] [Related]
17. Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals.
Mkrtchian A; Evans JW; Kraus C; Yuan P; Kadriu B; Nugent AC; Roiser JP; Zarate CA
Mol Psychiatry; 2021 Jul; 26(7):3292-3301. PubMed ID: 32929215
[TBL] [Abstract][Full Text] [Related]
18. Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression.
Sos P; Klirova M; Novak T; Kohutova B; Horacek J; Palenicek T
Neuro Endocrinol Lett; 2013; 34(4):287-93. PubMed ID: 23803871
[TBL] [Abstract][Full Text] [Related]
19. Anxiety during ketamine infusions is associated with negative treatment responses in major depressive disorder.
Aust S; Gärtner M; Basso L; Otte C; Wingenfeld K; Chae WR; Heuser-Collier I; Regen F; Cosma NC; van Hall F; Grimm S; Bajbouj M
Eur Neuropsychopharmacol; 2019 Apr; 29(4):529-538. PubMed ID: 30772118
[TBL] [Abstract][Full Text] [Related]
20. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities.
Strasburger SE; Bhimani PM; Kaabe JH; Krysiak JT; Nanchanatt DL; Nguyen TN; Pough KA; Prince TA; Ramsey NS; Savsani KH; Scandlen L; Cavaretta MJ; Raffa RB
J Clin Pharm Ther; 2017 Apr; 42(2):147-154. PubMed ID: 28111761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
